Literature DB >> 1465383

The PR264/c-myb connection: expression of a splicing factor modulated by a nuclear protooncogene.

A Sureau1, J Soret, M Vellard, J Crochet, B Perbal.   

Abstract

We have previously reported that expression of the c-myb gene in normal avian thymic cells proceeds through the intermolecular recombination of ET (thymus-specific) and c-myb coding sequences, thereby generating a novel type of c-myb product. Antisense transcripts expressed from the ET locus encode the extremely well-conserved splicing factor PR264/SC35. We now show that the human PR264 promoter sequences contain several myb-recognition elements that efficiently interact in vitro with the c-myb DNA-binding domain. Moreover, expression from the PR264 promoter is transactivated, both in vitro and in cultured cells, by different c-myb products. Thus, the PR264 gene is most likely a physiological target for the c-myb family of transcription factors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465383      PMCID: PMC50620          DOI: 10.1073/pnas.89.24.11683

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Functional analysis of c-Myb protein in T-lymphocytic cell lines shows that it trans-activates the c-myc promoter.

Authors:  J L Evans; T L Moore; W M Kuehl; T Bender; J P Ting
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Expression of the CD4 gene requires a Myb transcription factor.

Authors:  G Siu; A L Wurster; J S Lipsick; S M Hedrick
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

3.  Intermolecular recombination of the c-myb proto-oncogene coding sequences in chicken: clues for a mechanism.

Authors:  B Perbal; M Vellard
Journal:  C R Acad Sci III       Date:  1990

4.  The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene.

Authors:  S A Ness; A Marknell; T Graf
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

5.  UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein.

Authors:  B Stein; H J Rahmsdorf; A Steffen; M Litfin; P Herrlich
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

6.  Early decline in c-myb oncogene expression in the differentiation of human myeloblastic leukemia (ML-1) cells induced with 12-O-tetradecanoylphorbol-13-acetate.

Authors:  R W Craig; A Bloch
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

7.  C-myb proto-oncogene: evidence for intermolecular recombination of coding sequences.

Authors:  M Vellard; J Soret; E Viegas-Pequignot; F Galibert; V C Nguyen; B Dutrillaux; B Perbal
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

8.  Positive autoregulation of c-myb expression via Myb binding sites in the 5' flanking region of the human c-myb gene.

Authors:  N C Nicolaides; R Gualdi; C Casadevall; L Manzella; B Calabretta
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  Nucleotide sequence of chicken c-myb complementary DNA and implications for myb oncogene activation.

Authors:  D Rosson; E P Reddy
Journal:  Nature       Date:  1986 Feb 13-19       Impact factor: 49.962

View more
  11 in total

1.  Characterization of SRp46, a novel human SR splicing factor encoded by a PR264/SC35 retropseudogene.

Authors:  J Soret; R Gattoni; C Guyon; A Sureau; M Popielarz; E Le Rouzic; S Dumon; F Apiou; B Dutrillaux; H Voss; W Ansorge; J Stévenin; B Perbal
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

2.  Overexpression of A-myb induces basic fibroblast growth factor-dependent proliferation of chicken neuroretina cells.

Authors:  N Turque; S Plaza; K H Klempnauer; S Saule
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  Retroviral insertional activation of the c-myb proto-oncogene in a Marek's disease T-lymphoma cell line.

Authors:  E Le Rouzic; B Perbal
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed.

Authors:  Y Laabi; M P Gras; J C Brouet; R Berger; C J Larsen; A Tsapis
Journal:  Nucleic Acids Res       Date:  1994-04-11       Impact factor: 16.971

5.  Characterization of multiple alternative RNAs resulting from antisense transcription of the PR264/SC35 splicing factor gene.

Authors:  A Sureau; J Soret; C Guyon; C Gaillard; S Dumon; M Keller; P Crisanti; B Perbal
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

6.  Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing.

Authors:  S L Chew; H X Liu; A Mayeda; A R Krainer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

7.  Several mRNAs with variable 3' untranslated regions and different stability encode the human PR264/SC35 splicing factor.

Authors:  A Sureau; B Perbal
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

8.  Alteration of C-MYB DNA binding to cognate responsive elements in HL-60 variant cells.

Authors:  C Gaillard; E Le Rouzic; C Créminon; B Perbal
Journal:  Mol Pathol       Date:  2002-10

9.  Binding site analysis of c-Myb: screening of potential binding sites by using the mutation matrix derived from systematic binding affinity measurements.

Authors:  Q L Deng; S Ishii; A Sarai
Journal:  Nucleic Acids Res       Date:  1996-02-15       Impact factor: 16.971

10.  Casein kinase II phosphorylation site mutations in c-Myb affect DNA binding and transcriptional cooperativity with NF-M.

Authors:  M Oelgeschläger; J Krieg; J M Lüscher-Firzlaff; B Lüscher
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.